bibliographic entry 12498254 [be/12498254]
https://w3id.org/oc/corpus/be/12498254

is a
content
  • Salles, GA, Morschhauser, F, Solal-Celigny, P, Thieblemont, C, Lamy, T, Tilly, H. Obinutuzumab (GA101) in patients with relapsed/refractory indolent non-Hodgkin lymphoma: results from the phase II GAUGUIN study. J Clin Oncol (2013) 31: 2920–6. DOI: 10.1200/JCO.2012.46.9718 PMID: 23835715
references